Zimmer Biomet Holdings Inc
$ 95.48
0.74%
20 Apr - close price
- Market Cap 18,680,855,000 USD
- Current Price $ 95.48
- High / Low $ 96.25 / 93.97
- Stock P/E 26.90
- Book Value 64.95
- EPS 3.55
- Next Earning Report 2026-04-28
- Dividend Per Share $0.96
- Dividend Yield 1.01 %
- Next Dividend Date 2026-04-30
- ROA 0.04 %
- ROE 0.06 %
- 52 Week High 107.45
- 52 Week Low 84.36
About
Zimmer Biomet is a publicly traded medical device company. The company is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
Analyst Target Price
$102.95
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-04 | 2025-10-30 | 2025-08-07 | 2025-05-05 | 2025-02-06 | 2024-10-30 | 2024-08-07 | 2024-05-02 | 2024-02-08 | 2023-11-07 | 2023-08-01 | 2023-05-02 |
| Reported EPS | 2.42 | 1.9 | 2.07 | 1.81 | 2.31 | 1.74 | 2.01 | 1.94 | 2.2 | 1.65 | 1.82 | 1.89 |
| Estimated EPS | 2.3978 | 1.88 | 1.98 | 1.77 | 2.29 | 1.74 | 1.99 | 1.87 | 2.15 | 1.6 | 1.81 | 1.64 |
| Surprise | 0.0222 | 0.02 | 0.09 | 0.04 | 0.02 | 0 | 0.02 | 0.07 | 0.05 | 0.05 | 0.01 | 0.25 |
| Surprise Percentage | 0.9258% | 1.0638% | 4.5455% | 2.2599% | 0.8734% | 0% | 1.005% | 3.7433% | 2.3256% | 3.125% | 0.5525% | 15.2439% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-04-28 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 1.86 |
| Currency | USD |
Previous Dividend Records
| Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-04-30 | 2026-01-30 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 |
| Amount | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 |
Next Dividend Records
| Dividend per share (year): | $0.96 |
| Dividend Yield | 1.01% |
| Next Dividend Date | 2026-04-30 |
| Ex-Dividend Date | 2026-03-31 |
Recent News: ZBH
2026-04-21 10:46:47
Zimmer Biomet (NYSE:ZBH) is scheduled to release its Q1 2026 earnings before market open on Tuesday, April 28th. Analysts anticipate earnings of $1.86 per share and revenue of $2.0555 billion. The medical equipment provider had previously exceeded estimates in Q4 2025, reporting $2.42 EPS on $2.24 billion in revenue, and has a consensus "Hold" rating from analysts with a target price of $105.95.
2026-04-21 10:00:00
Zimmer Biomet (ZBH) is expected to report increased earnings and revenues for the quarter ending March 2026, with an anticipated EPS of $1.86 and revenues of $2.05 billion. Despite the positive year-over-year growth projections, the company's Zacks Earnings ESP is slightly negative at -0.09% and it holds a Zacks Rank #4, making an earnings beat difficult to predict conclusively. Investors should consider these factors along with past performance, where Zimmer Biomet has consistently beaten EPS estimates over the last four quarters.
2026-04-21 00:00:30
Indiana University and Zimmer Biomet have formed a strategic partnership to accelerate technology development in orthopedics, aiming to reduce the time from invention to implantation for patients. This multi-year collaboration will also focus on preparing IU students for careers in the orthopedic sector, integrating academic research with industry expertise. The partnership involves the IU Kelley School of Business and supports the Indiana Musculoskeletal Health Partnership for the Advancement of Care & Treatment (IMPACT) to solidify Indiana's role as a global hub for orthopedic innovation.
2026-04-20 12:08:46
Zimmer Biomet (ZBH) is expected to announce its Q1 2026 earnings on April 28, with Zacks anticipating revenues of $2.05 billion and EPS of $1.86. The company's Knee and Hips portfolios, along with its S.E.T. business and Technology & Data segment, are projected to drive growth, supported by new product introductions, FDA clearances, and strategic acquisitions like Paragon 28. Analysts are looking for continued strong performance, building on previous quarters where ZBH consistently topped earnings estimates.
2026-04-20 12:08:42
Zimmer Biomet (ZBH) is expected to announce its first-quarter 2026 earnings on April 28. The company's performance is anticipated to be driven by growth in its Knee and Hips portfolios, including new product introductions and robotic surgery technologies. Despite potential positive factors, the company holds a Zacks Rank #4 (Sell) with a negative Earnings ESP, suggesting a lower probability of an earnings beat based on the Zacks model.
2026-04-20 12:07:57
Medtronic (NYSE:MDT) has completed its $585 million acquisition of CathWorks, gaining its AI-driven FFRangio® System for wire-free and drug-free assessment of coronary artery disease. The acquisition strengthens Medtronic’s interventional cardiology portfolio and expands access to this innovative technology in the U.S., Europe, and Japan. The deal is expected to be immaterial to Medtronic's FY2027 GAAP and adjusted EPS, becoming neutral to accretive thereafter.
